E-LIB Suche - Ergebnisse für: DEEG, H. JOACHIM

1

Correlation between peripheral blood and bone marrow mutati..:

DeZern, Amy E. ; Goll, Johannes B. ; Jensen, Travis L....
Blood Neoplasia. 1 (2024) 3 - p. 100026 , 2024

2

MODULAATE (Part 1): An Open-Label, Dose-Finding Phase 2 Eva..:

Waller, Edmund K. ; Horwitz, Mitchell ; Anand, Sarah...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S261 , 2024

Link: https://doi.org/10.1016/..

3

Oral decitabine–cedazuridine versus intravenous decitabine ..:

Garcia-Manero, Guillermo ; McCloskey, James ; Griffiths, Elizabeth A...
The Lancet Haematology. 11 (2024) 1 - p. e15-e26 , 2024

Link: https://doi.org/10.1016/..

4

Association between Prior Cytotoxic Therapy, Antecedent Hem..:

Orvain, Corentin ; Rodríguez-Arbolí, Eduardo ; Othus, Megan...
Cancers. 15 (2023) 2 - p. 352 , 2023

Link: https://doi.org/10.3390/..

5

Prognostic landscape of mitochondrial genome in myelodyspla..:

Dong, Jing ; Buradagunta, Christopher Staffi ; Zhang, Tao...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

JAK2V617F mutation and associated chromosomal alterations i..:

Rafati, Maryam ; Brown, Derek W. ; Zhou, Weiyin...
Blood Advances. 7 (2023) 24 - p. 7506-7515 , 2023

Link: https://doi.org/10.1182/..

7

POSTER: MDS-634 Efficacy and Safety of Oral Decitabine/Ceda..:

Savona, Michael R. ; McCloskey, James K. ; Griffiths, Elizabeth A....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S186 , 2023

Link: https://doi.org/10.1016/..

8

MDS-634 Efficacy and Safety of Oral Decitabine/Cedazuridine..:

Savona, Michael R. ; McCloskey, James K. ; Griffiths, Elizabeth A....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S375-S376 , 2023

Link: https://doi.org/10.1016/..

9

Whole-genome sequencing identifies novel predictors for hem..:

Zhang, Tao ; Auer, Paul ; Dong, Jing...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

10

P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (..:

Robert Savona, Michael ; K Mccloskey, James ; A. Griffiths, Elizabeth...
HemaSphere. 7 (2023) S3 - p. e1342620 , 2023

Link: https://doi.org/10.1097/..

11

Phase II Trial of Eprenetapopt (APR-246) in Combination wit..:

Mishra, Asmita ; Tamari, Roni ; DeZern, Amy E....
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S34-S35 , 2022

Link: https://doi.org/10.1016/..

12

Prediction of Busulfan Clearance by Predose Plasma Metabolo..:

McCune, Jeannine S. ; Navarro, Sandi L. ; Baker, K. Scott...
Clinical Pharmacology & Therapeutics. 113 (2022) 2 - p. 370-379 , 2022

Link: https://doi.org/10.1002/..

13

Not all patients with AML over 60 years of age should be of..:

Deeg, H. Joachim
Blood Advances. 6 (2022) 5 - p. 1623-1627 , 2022

Link: https://doi.org/10.1182/..

14

Disease progression, treatments, hospitalization, and clini..:

Holtan, Shernan G. ; Yu, Jingbo ; Choe, Hannah K....
Bone Marrow Transplantation. 57 (2022) 10 - p. 1581-1585 , 2022

Link: https://doi.org/10.1038/..

15

Germline-somatic JAK2 interactions are associated with clon..:

Brown, Derek W. ; Zhou, Weiyin ; Wang, Youjin...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..